pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Entyvio · news · pharmadog
← back to Entyvio
News mentioning Entyvio
10
stories
3d
Lilly, Foghorn part ways; Wave’s FDA-approved plans
biopharma dive
24d
Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successes
fiercebiotech
26d
Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics
fiercebiotech
26d
Spyre's 3-pronged IBD strategy on track as IL-23 antibody rounds off trio of phase 2 wins
fiercebiotech
Aug 5, 26
5 NextGen winners who went public this year (and which ones are hiring)
biospace
Aug 3, 26
Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea
fiercebiotech
Jul 1, 26
Abivax shares surge as worries subside over immune drug’s cancer risk
biopharma dive
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 2, 26
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
biopharma dive
May 8, 26
Odyssey, on second try, snags $279M in an IPO
biopharma dive
